Trial intelligence / Profile preview

Bupivacaine versus ketorolac wound infiltration for post-caesarean pain

PACTR202605718359093Phase 1Not yet recruiting

Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in postoperative pain comparing Bupivacaine wound infiltration with Ketorolac wound infiltration (2 arms). Primary endpoint: Mean pain scores using visual analogue scale. Planned start May 2026; status: not yet recruiting.

02

Drugs

bupivacaineketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202605718359093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202605718359093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call